Disclosure Statement

You must select "I Understand" to see results.

The physicians in our directory are members of a Children’s Health hospital medical staff or are credentialed by Children’s Health for managed care participation. Some physicians are employed by Children’s Health, some are employed elsewhere, and some maintain an independent medical practice. There is no fee for being listed in our directory. The physicians populating your search results are selected based on the criteria that you provide and are then listed alphabetically. If a physician is no longer on a Children’s Health medical staff or participating in a Children’s Health managed care agreement, he/she would not be eligible to be listed in our directory.

Peter Victor Sguigna, MD $$

Pediatric Neurologist

Assistant Professor at UT Southwestern Medical Center

Languages Spoken:
English
UT Southwestern Pediatric Group

Education and Training

Medical School
UT Southwestern Medical Center (2014)
Residency
UT Southwestern Medical Center (2018), Neurology
Fellowship
Children's Medical Center Dallas (2020), Neuroimmunology
Post-graduate School
UT Southwestern Medical Center (2019)
Board Certification
American Board of Psychiatry and Neurology
  • Research Interests

    • Clinical trials
    • Medical devices
    • MOG antibody associated disorders
    • Multiple sclerosis
    • Neuro-ophthalmology
    • Neuromyelitis optica spectrum disorder
    • Optic neuritis
    • Visual dysfunction
  • Publications

    • Correction: Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM- Au8, in the REPAIR phase 2 clinical trials (Journal of Nanobiotechnology, (2023), 21, 1, (478), 10.1186/s12951-023-02236-z) Ren J, Dewey RB, Rynders A, Evan J, Evan J, Ligozio S, Ho KS, Sguigna PV, Glanzman R, Hotchkin MT, Dewey RB, Greenberg BM Journal of Nanobiotechnology 2024 Dec 22
    • Cladribine tablets after treatment with natalizumab (CLADRINA) – rationale and design. Sguigna PV, Hussain RZ, Okai A, Blackburn KM, Tardo L, Madinawala M, Korich J, Lebson LA, Kaplan J, Salter A, Manouchehri N, Stuve O Therapeutic Advances in Neurological Disorders 2024 Jan 17
    • Evidence of brain target engagement in Parkinson’s disease and multiple sclerosis by the investigational nanomedicine, CNM-Au8, in the REPAIR phase 2 clinical trials. Ren J, Rynders A, Evan J, Evan J, Ligozio S, Ho KS, Sguigna PV, Glanzman R, Hotchkin MT, Dewey RB, Greenberg BM Journal of Nanobiotechnology 2023 Dec 21
    • Subclinical optic neuritis in pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Nguyen L, Wang CX, Conger DL, Sguigna PV, Singh S, Greenberg BM Multiple Sclerosis and Related Disorders 2023 Aug 76
    • A narrative review of neuro-ophthalmologic disease in African Americans and Hispanics with multiple sclerosis. Tardo L, Salter A, Truong-Le M, Horton L, Blackburn KM, Sguigna PV Therapeutic Advances in Chronic Disease 2023 Jan 14
    • Disease associations of excessive daytime sleepiness in multiple sclerosis: A prospective study. Sguigna PV, Toranian S, Tardo LM, Blackburn KM, Horton LA, Conger D, Meltzer E, Hogan RN, McCreary M, Zee PC, Takahashi JS, Greenberg BM Multiple Sclerosis Journal - Experimental, Translational and Clinical 2023 Jan 9
    • A cross-sectional natural history study of aspartylglucosaminuria. Goodspeed K, Horton DK, Lowden A, Sguigna PV, Booth T, Wang ZJ, Edgar VB JIMD Reports 2022 Sep 63 425-433
    • The sequential natalizumab – alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial – Part I: Rationale and objectives. Hussain RZ, Sguigna PV, Okai A, Wright C, Madinawala M, Bass AD, Cutter GR, Manouchehri N, Stuve O Journal of Central Nervous System Disease 2022 Aug 14
    • Application of the International Interocular Difference Thresholds into Practice: Localising the Patient Experience. Sguigna PV, Tardo LM, Blackburn KM, Horton LA, Conger DL, Hogan RN, McCreary MC, Greenberg BM Neuro-Ophthalmology 2022 46 375-382
    • Asymptomatic retinal vasculopathy in neuropsychiatric systemic lupus erythematosus. Sguigna PV, Tardo L, Conger D, Hogan R, Greenberg BM Journal of the Neurological Sciences 2021 Nov 430
    • Utilization of Visual Acuity Retroilluminated Charts for the Assessment of Afferent Visual System Dysfunction in a Pediatric Neuroimmunology Population. Sguigna PV, McCreary MC, Conger DL, Graves JS, Benson LA, Waldman AT, Greenberg BM Journal of Neuro-Ophthalmology 2021 Mar 41 19-23
    • Utilization of video oculography to quantify oculomotor dysfunction in anti-DPPX encephalitis: A case study. Blackburn K, Vernino S, Sguigna P Multiple Sclerosis and Related Disorders 2020 Nov 46
  • Professional Activities

    • American Academy of Neurology
    • North American Neuro-Ophthalmology Society
  • Awards and Honors

    • President’s Research Council (2020-2021)
    • Scholar Award (2018-2020), Center for Translational Medicine
    • Best Fellow Poster Award (2019), Neurology Research Day
    • Educational Travel Grant (2019), Americas Committee for Treatment and Research in Multiple Sclerosis
    • Early Stage Investigator Award (2018-2019), NeuroNEXT
    • Best Poster Award (2017), UTSW Research Day Committee

Where I Provide Care: